Evidence map›Paper›PMID 37527898›Full record

ArticleBMJ open2023

Bedtime versus morning use of antihypertensives in frail continuing care residents (BedMed-Frail): protocol for a prospective, randomised, open-label, blinded end-point pragmatic trial.

Scott R Garrison, Erik Youngson, Danielle A Perry, Farah N Campbell, Michael R Kolber, Christina Korownyk, Gary Michael Allan, Lee Green, Jeffrey Bakal

Registry-linked trialOpen access · goldAbstract readClinical Trial Protocol
In one paragraph

Article in BMJ open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04054648 (Does the Potential Benefit of Bedtime Antihypertensive Prescribing Extend to Frail Populations? The "BedMed-Frail" Randomized Controlled Trial), which is not on this map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04054648 nacompletednot on this map

Does the Potential Benefit of Bedtime Antihypertensive Prescribing Extend to Frail Populations? The "BedMed-Frail" Randomized Controlled Trial

TypeinterventionalSponsorUniversity of AlbertaRan2020 to 2024Enrolled776ConditionsHypertension, DementiaArmsBedtime administration of the participant's pre-existing antihypertensive medications
3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Review
  6. Review
  7. The Japanese Society of Hypertension Guidelines for the management of elevated blood pressure and hypertension 2025 (JSH2025).Hypertension research : official journal of the Japanese Society of Hypertension · 2026
    Article
  8. Review
  9. Article
  10. Does the timing of blood pressure medication really matter?International journal of cardiology. Cardiovascular risk and prevention · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Scott R GarrisonFamily Medicine, University of Alberta Faculty of Medicine & Dentistry, Edmonton, Alberta, Canada scott.garrison@ualberta.ca.ORCID 0000-0002-7024-2158
Erik YoungsonProvincial Research Data Services, Alberta Health Services, Edmonton, Alberta, Canada.
Danielle A PerryPragmatic Trials Collaborative, University of Alberta Faculty of Medicine & Dentistry, Edmonton, Alberta, Canada.
Farah N CampbellPragmatic Trials Collaborative, University of Alberta Faculty of Medicine & Dentistry, Edmonton, Alberta, Canada.
Michael R KolberFamily Medicine, University of Alberta Faculty of Medicine & Dentistry, Edmonton, Alberta, Canada.
Christina KorownykFamily Medicine, University of Alberta Faculty of Medicine & Dentistry, Edmonton, Alberta, Canada.
Gary Michael AllanPragmatic Trials Collaborative, University of Alberta Faculty of Medicine & Dentistry, Edmonton, Alberta, Canada.
Lee GreenFamily Medicine, University of Alberta Faculty of Medicine & Dentistry, Edmonton, Alberta, Canada.ORCID 0000-0002-1789-7366
Jeffrey BakalProvincial Research Data Services, Alberta Health Services, Edmonton, Alberta, Canada.
University of Alberta · CAAlberta Health Services · CA

Funding

CIHR REF#: 151212
6 · The paper itself

Abstract

introductionBedMed-Frail explores risks and benefits of switching antihypertensives from morning to bedtime in a frail population at greater risk of hypotensive adverse effects. METHODS AND ANALYSIS: ETHICS AND DISSEMINATION: BedMed-Frail has ethical approval from the University of Alberta Health Ethics Review Board (Pro00086129) and will publish results in a peer-reviewed journal. TRIAL REGISTRATION NUMBER: NCT04054648.

Indexed as

COVID-19AgedAged, 80 and overAlbertaAntihypertensive AgentsFemaleFrail ElderlyHumansMalePragmatic Clinical Trials as TopicProspective StudiesRandomized Controlled Trials as TopicSARS-CoV-2Treatment OutcomeAntihypertensive AgentsCardiologyCLINICAL PHARMACOLOGYClinical trialsGERIATRIC MEDICINEHypertensionPrimary Care

Identifiers

PMID37527898
PMCPMC10394547
OpenAlexW4385453865

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.